Skip Navigation


IJE Advance Access originally published online on February 28, 2005
International Journal of Epidemiology 2005 34(3):577-584; doi:10.1093/ije/dyi023
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/3/577    most recent
dyi023v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Costello, C
Right arrow Articles by Duerr, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costello, C
Right arrow Articles by Duerr, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2005; all rights reserved.

Article

HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival

C Costello1,2, KE Nelson6,*, V Suriyanon3, S Sennun3, S Tovanabutra4, CM Heilig1, S Shiboski5, DJ Jamieson1, V Robison1, K Rungruenthanakit3 and A Duerr1,7

1 Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA
2 CONRAD, Eastern Virginia Medical School, 1611 North Kent Street, Suite 806, Arlington, VA 22209, USA
3 Research Institute of Health Science, PO Box 80, Chiang Mai University, Thailand
4 Henry M. Jackson Foundation Suite 600, Rockville, MD 20852, USA
5 University of California at San Francisco, San Francisco, CA 94143, USA
6 Johns Hopkins University, Bloomberg School of Public Health, 615 N. Wolfe Street Room E713, Baltimore, MD 21205, USA
7 HIV Vaccine Trials Network, 901 Boren Avenue, Suite 1320, Seattle, WA 98104, USA

* Corresponding author. Johns Hopkins University, Bloomberg School of Public Health, 615 N. Wolfe Street/Room E7132, Baltimore, MD 21205, USA. E-mail: kenelson{at}jhsph.edu

Background In the continuing effort to introduce antiretroviral therapy in resource-limited settings, there is a need to understand differences between natural history of HIV in different populations and to identify feasible clinical measures predictive of survival.

Methods We examined predictors of survival among 836 heterosexuals who were infected with HIV subtype CRF01_AE in Thailand.

Results From 1993 to 1999, 269 (49.4%) men and 65 (25.7%) women died. The median time from the estimated seroconversion to death was 7.8 years (95% confidence interval 7.0–9.1). Men and women with enrolment CD4 counts <200 cells/µl had about 2 and 11 times greater risk of death than those with CD4 counts of 200–500 and >500, respectively. Measurements available in resource-limited settings, including total lymphocyte count (TLC), anaemia, and low body mass index (BMI), also predicted survival. Men with two or more of these predictors had a median survival of 0.8 (0.5–1.8) years, compared with 2.7 (1.9–3.3) years for one predictor and 4.9 (4.1–5.2) years for no predictors.

Conclusions The time from HIV infection to death appears shorter among this Thai population than among antiretroviral naïve Western populations. CD4 count and viral load (VL) were strong, independent predictors of survival. When CD4 count and VL are unavailable, individuals at high risk for shortened HIV survival may be identified by a combination of low TLC, anaemia, and low BMI. This combination of accessible clinical measures of the disease stage may be useful for medical management in resource-limited settings.


Keywords HIV-1, survival, CD4 lymphocyte count, viral load, lymphocyte count, Thailand

Accepted 16 December 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Sex. Transm. Infect.Home page
The eligibility for ART in lower income countries
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Sex. Transm. Inf., August 1, 2008; 84(Suppl_1): i31 - i36.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. S. Taylor, M. E. Sobieszczyk, F. E. McCutchan, and S. M. Hammer
The Challenge of HIV-1 Subtype Diversity
N. Engl. J. Med., April 10, 2008; 358(15): 1590 - 1602.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. Egger, A. Boulle, M. Schechter, and P. Miotti
Antiretroviral therapy in resource-poor settings: scaling up inequalities?
Int. J. Epidemiol., June 1, 2005; 34(3): 509 - 512.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
V. Miller
Commentary: Sifting through the maze of viral and host diversity and HIV/AIDS clinical progression
Int. J. Epidemiol., June 1, 2005; 34(3): 584 - 585.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.